Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00672802 · ClinicalTrials.gov registry record · Phase 2
Safety of Ramelteon in Subjects With Mild to Moderate Chronic Obstructive Pulmonary Disease
A Phase 2 study, sponsored by Takeda.
- Completed
- Registry status
- Phase 2
- Development phase
- 26
- Enrollment target
NCT00672802 is a Phase 2 study that has completed, run by Takeda. The registered enrollment target is 26 participants.
The verdict
NCT00672802, a Phase 2 study, has completed, sponsored by Takeda.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 26 participants
- Enrollment target
Study Summary
This purpose of this study is to assess the safety of ramelteon, once daily (QD), in subjects with chronic obstructive pulmonary disease.
Interventions
- DRUG Ramelteon and Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2003-08 |
| Est. Completion | 2004-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00672802
The ClinicalTrials.gov registry entry for NCT00672802 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Takeda, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ramelteon and Placebo is the first listed.
NCT00672802 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00672802 about?
NCT00672802 is a clinical study titled "Safety of Ramelteon in Subjects With Mild to Moderate Chronic Obstructive Pulmonary Disease". This purpose of this study is to assess the safety of ramelteon, once daily (QD), in subjects with chronic obstructive pulmonary disease.
What is the current status of trial NCT00672802?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 26 participants. The study started on 2003-08. Estimated completion is 2004-03.
What interventions are being tested in trial NCT00672802?
The interventions under investigation include: Ramelteon and Placebo (DRUG).
Who is sponsoring clinical trial NCT00672802?
This trial is sponsored by Takeda, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.